Logo image of EXOD

EXODUS MOVEMENT INC - A (EXOD) Stock Fundamental Analysis

NYSEARCA:EXOD - NYSE Arca - US30209R1068 - Common Stock - Currency: USD

44.09  +4.9 (+12.5%)

After market: 44.09 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to EXOD. EXOD was compared to 285 industry peers in the Software industry. While EXOD has a great health rating, its profitability is only average at the moment. EXOD is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

EXOD had positive earnings in the past year.
EXOD had a negative operating cash flow in the past year.
In multiple years EXOD reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: EXOD reported negative operating cash flow in multiple years.
EXOD Yearly Net Income VS EBIT VS OCF VS FCFEXOD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2024 0 20M -20M 40M 60M 80M 100M

1.2 Ratios

EXOD's Return On Assets of 39.22% is amongst the best of the industry. EXOD outperforms 99.65% of its industry peers.
With an excellent Return On Equity value of 43.86%, EXOD belongs to the best of the industry, outperforming 94.39% of the companies in the same industry.
EXOD's Return On Invested Capital of 9.49% is amongst the best of the industry. EXOD outperforms 85.61% of its industry peers.
Industry RankSector Rank
ROA 39.22%
ROE 43.86%
ROIC 9.49%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EXOD Yearly ROA, ROE, ROICEXOD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2024 0 20 -20 40

1.3 Margins

EXOD has a better Profit Margin (97.15%) than 97.54% of its industry peers.
EXOD's Operating Margin of 26.43% is amongst the best of the industry. EXOD outperforms 92.98% of its industry peers.
In the last couple of years the Operating Margin of EXOD has declined.
The Gross Margin of EXOD (60.41%) is comparable to the rest of the industry.
EXOD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 26.43%
PM (TTM) 97.15%
GM 60.41%
OM growth 3Y-20.86%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.53%
GM growth 5Y42.83%
EXOD Yearly Profit, Operating, Gross MarginsEXOD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2024 0 50

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EXOD is destroying value.
EXOD has more shares outstanding than it did 5 years ago.
EXOD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EXOD Yearly Shares OutstandingEXOD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2024 5M 10M 15M 20M 25M
EXOD Yearly Total Debt VS Total AssetsEXOD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2024 50M 100M 150M 200M 250M

2.2 Solvency

EXOD has an Altman-Z score of 26.55. This indicates that EXOD is financially healthy and has little risk of bankruptcy at the moment.
EXOD has a Altman-Z score of 26.55. This is amongst the best in the industry. EXOD outperforms 95.44% of its industry peers.
EXOD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 26.55
ROIC/WACC0.86
WACC11.06%
EXOD Yearly LT Debt VS Equity VS FCFEXOD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 9.92 indicates that EXOD has no problem at all paying its short term obligations.
The Current ratio of EXOD (9.92) is better than 95.09% of its industry peers.
EXOD has a Quick Ratio of 9.92. This indicates that EXOD is financially healthy and has no problem in meeting its short term obligations.
EXOD has a better Quick ratio (9.92) than 95.09% of its industry peers.
Industry RankSector Rank
Current Ratio 9.92
Quick Ratio 9.92
EXOD Yearly Current Assets VS Current LiabilitesEXOD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2024 20M 40M 60M 80M

More info and screens

5

3. Growth

3.1 Past

Measured over the past years, EXOD shows a very strong growth in Revenue. The Revenue has been growing by 71.14% on average per year.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3Y6.65%
Revenue growth 5Y71.14%
Sales Q2Q%N/A

3.2 Future

EXOD is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -10.15% yearly.
Based on estimates for the next years, EXOD will show a very strong growth in Revenue. The Revenue will grow by 24.69% on average per year.
EPS Next Y-47.01%
EPS Next 2Y-10.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.8%
Revenue Next 2Y24.69%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
EXOD Yearly Revenue VS EstimatesEXOD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
EXOD Yearly EPS VS EstimatesEXOD Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0.5 1 1.5 2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 12.63, the valuation of EXOD can be described as correct.
EXOD's Price/Earnings ratio is rather cheap when compared to the industry. EXOD is cheaper than 87.37% of the companies in the same industry.
EXOD's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.64.
Based on the Price/Forward Earnings ratio of 34.79, the valuation of EXOD can be described as expensive.
EXOD's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. EXOD is cheaper than 62.11% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.44, EXOD is valued quite expensively.
Industry RankSector Rank
PE 12.63
Fwd PE 34.79
EXOD Price Earnings VS Forward Price EarningsEXOD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EXOD indicates a somewhat cheap valuation: EXOD is cheaper than 73.68% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 33.07
EXOD Per share dataEXOD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The decent profitability rating of EXOD may justify a higher PE ratio.
A cheap valuation may be justified as EXOD's earnings are expected to decrease with -10.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-10.15%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

EXOD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EXODUS MOVEMENT INC - A

NYSEARCA:EXOD (4/23/2025, 8:04:02 PM)

After market: 44.09 0 (0%)

44.09

+4.9 (+12.5%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-06 2025-03-06/amc
Earnings (Next)05-13 2025-05-13
Inst Owners0.13%
Inst Owner Change0%
Ins Owners18.05%
Ins Owner Change-4.24%
Market Cap1.26B
Analysts87.27
Price Target49.27 (11.75%)
Short Float %0.46%
Short Ratio0.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-77.48%
Min EPS beat(2)-89.5%
Max EPS beat(2)-65.46%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)12.11%
Min Revenue beat(2)-18.8%
Max Revenue beat(2)43.03%
Revenue beat(4)2
Avg Revenue beat(4)10.7%
Min Revenue beat(4)-18.8%
Max Revenue beat(4)43.03%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-19.5%
PT rev (3m)83.65%
EPS NQ rev (1m)-63.53%
EPS NQ rev (3m)-3.12%
EPS NY rev (1m)255%
EPS NY rev (3m)-9.96%
Revenue NQ rev (1m)3.93%
Revenue NQ rev (3m)37.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.53%
Valuation
Industry RankSector Rank
PE 12.63
Fwd PE 34.79
P/S 10.85
P/FCF N/A
P/OCF N/A
P/B 4.9
P/tB 23.84
EV/EBITDA 33.07
EPS(TTM)3.49
EY7.92%
EPS(NY)1.27
Fwd EY2.87%
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)-0.42
OCFYN/A
SpS4.07
BVpS9
TBVpS1.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 39.22%
ROE 43.86%
ROCE 10.99%
ROIC 9.49%
ROICexc 12.56%
ROICexgc 399.35%
OM 26.43%
PM (TTM) 97.15%
GM 60.41%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-4.25%
ROICexcg growth 5YN/A
ROICexc growth 3Y-46.6%
ROICexc growth 5YN/A
OM growth 3Y-20.86%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.53%
GM growth 5Y42.83%
F-ScoreN/A
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 8.88%
Cap/Sales 0.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.92
Quick Ratio 9.92
Altman-Z 26.55
F-ScoreN/A
WACC11.06%
ROIC/WACC0.86
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-47.01%
EPS Next 2Y-10.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3Y6.65%
Revenue growth 5Y71.14%
Sales Q2Q%N/A
Revenue Next Year22.8%
Revenue Next 2Y24.69%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3Y-15.6%
EBIT growth 5YN/A
EBIT Next Year11.28%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A